2023-09-28 14:46:10 +00:00
|
|
|
abstract: 'Global disparities in breast cancer outcomes are attributable to a
|
|
|
|
|
|
|
|
|
|
sizable gap between evidence and practice in breast cancer control and
|
|
|
|
|
|
|
|
|
|
management. Dissemination and implementation science (D\&IS) seeks to
|
|
|
|
|
|
|
|
|
|
understand how to promote the systematic uptake of evidence-based
|
|
|
|
|
|
|
|
|
|
interventions and/or practices into real-world contexts. D\&IS methods
|
|
|
|
|
|
|
|
|
|
are useful for selecting strategies to implement evidence-based
|
|
|
|
|
|
|
|
|
|
interventions, adapting their implementation to new settings, and
|
|
|
|
|
|
|
|
|
|
evaluating the implementation process as well as its outcomes to
|
|
|
|
|
|
|
|
|
|
determine success and failure, and adjust accordingly. Process models,
|
|
|
|
|
|
|
|
|
|
explanatory theories, and evaluation frameworks are used in D\&IS to
|
|
|
|
|
|
|
|
|
|
develop implementation strategies, identify implementation outcomes, and
|
|
|
|
|
|
|
|
|
|
design studies to evaluate these outcomes. In breast cancer control and
|
|
|
|
|
|
|
|
|
|
management, research has been translated into evidence-based,
|
|
|
|
|
|
|
|
|
|
resource-stratified guidelines by the Breast Health Global Initiative
|
|
|
|
|
|
|
|
|
|
and others. D\&IS should be leveraged to optimize the implementation of
|
|
|
|
|
|
|
|
|
|
these guidelines, and other evidence-based interventions, into practice
|
|
|
|
|
|
|
|
|
|
across the breast cancer care continuum, from optimizing public
|
|
|
|
|
|
|
|
|
|
education to promoting early detection, increasing guideline-concordant
|
|
|
|
|
|
|
|
|
|
clinical practice among providers, and analyzing and addressing barriers
|
|
|
|
|
|
|
|
|
|
and facilitators in health care systems. Stakeholder engagement through
|
|
|
|
|
|
|
|
|
|
processes such as co-creation is critical. In this article, the authors
|
|
|
|
|
|
|
|
|
|
have provided a primer on the contribution of D\&IS to phased
|
|
|
|
|
|
|
|
|
|
implementation of global breast cancer control programs, provided 2 case
|
|
|
|
|
|
|
|
|
|
examples of ongoing D\&IS research projects in Tanzania, and concluded
|
|
|
|
|
|
|
|
|
|
with recommendations for best practices for researchers undertaking this
|
|
|
|
|
|
|
|
|
|
work.'
|
|
|
|
|
affiliation: 'Rositch, AF (Corresponding Author), Johns Hopkins Bloomberg Sch Publ
|
|
|
|
|
Hlth, Dept Epidemiol, 615 N Wolfe St,Room E6150, Baltimore, MD 21205 USA.
|
|
|
|
|
|
|
|
|
|
Rositch, Anne F., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe
|
|
|
|
|
St,Room E6150, Baltimore, MD 21205 USA.
|
|
|
|
|
|
|
|
|
|
Unger-Saldana, Karla, CONACYT Natl Canc Inst, Mexico City, DF, Mexico.
|
|
|
|
|
|
|
|
|
|
DeBoer, Rebecca J., Univ Calif San Francisco, Helen Diller Family Comprehens Canc
|
|
|
|
|
Ctr, Global Canc Program, San Francisco, CA 94143 USA.
|
|
|
|
|
|
|
|
|
|
Ng''ang''a, Anne, Minist Hlth, Natl Canc Control Program, Nairobi, Kenya.
|
|
|
|
|
|
|
|
|
|
Weiner, Bryan J., Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.'
|
|
|
|
|
author: Rositch, Anne F. and Unger-Saldana, Karla and DeBoer, Rebecca J. and Ng'ang'a,
|
|
|
|
|
Anne and Weiner, Bryan J.
|
|
|
|
|
author-email: arositch@jhu.edu
|
|
|
|
|
author_list:
|
|
|
|
|
- family: Rositch
|
|
|
|
|
given: Anne F.
|
|
|
|
|
- family: Unger-Saldana
|
|
|
|
|
given: Karla
|
|
|
|
|
- family: DeBoer
|
|
|
|
|
given: Rebecca J.
|
|
|
|
|
- family: Ng'ang'a
|
|
|
|
|
given: Anne
|
|
|
|
|
- family: Weiner
|
|
|
|
|
given: Bryan J.
|
|
|
|
|
da: '2023-09-28'
|
|
|
|
|
doi: 10.1002/cncr.32877
|
|
|
|
|
eissn: 1097-0142
|
|
|
|
|
files: []
|
|
|
|
|
issn: 0008-543X
|
|
|
|
|
journal: CANCER
|
|
|
|
|
keywords: 'breast cancer; Breast Health Global Initiative; Consolidated Framework
|
|
|
|
|
|
|
|
|
|
for Implementation Research (CFIR); dissemination and implementation
|
|
|
|
|
|
|
|
|
|
science; Tanzania'
|
|
|
|
|
keywords-plus: 'GUIDELINE IMPLEMENTATION; HEALTH-CARE; STRATEGIES; INTERVENTIONS;
|
|
|
|
|
|
|
|
|
|
IMPROVEMENT; ONCOLOGY; INCOME; INNOVATIONS; PREVENTION; EVALUATE'
|
|
|
|
|
language: English
|
|
|
|
|
month: MAY 15
|
|
|
|
|
number: '10'
|
|
|
|
|
number-of-cited-references: '83'
|
|
|
|
|
orcid-numbers: Unger-Saldaña, Karla/0000-0002-9689-498X
|
|
|
|
|
pages: 2394-2404
|
|
|
|
|
papis_id: 33a2e8ff6c72d6663f2ee4dff7e9390e
|
|
|
|
|
ref: Rositch2020roledissemination
|
|
|
|
|
researcherid-numbers: Unger-Saldaña, Karla/AFI-7335-2022
|
|
|
|
|
times-cited: '27'
|
|
|
|
|
title: 'The role of dissemination and implementation science in global breast cancer
|
|
|
|
|
control programs: Frameworks, methods, and examples'
|
2023-10-01 08:15:07 +00:00
|
|
|
type: article
|
2023-09-28 14:46:10 +00:00
|
|
|
unique-id: WOS:000529295100006
|
|
|
|
|
usage-count-last-180-days: '2'
|
|
|
|
|
usage-count-since-2013: '7'
|
|
|
|
|
volume: '126'
|
|
|
|
|
web-of-science-categories: Oncology
|
|
|
|
|
year: '2020'
|
